| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 235 | 7.759 | 14.095 | 28.104 | 26.224 | 31.719 | 49.418 | 80.732 | 89.880 |
| Total Income - EUR | - | 235 | 7.759 | 14.095 | 28.104 | 26.224 | 31.719 | 49.441 | 80.737 | 89.880 |
| Total Expenses - EUR | - | 213 | 1.457 | 3.658 | 5.813 | 1.836 | 3.751 | 3.341 | 10.199 | 11.806 |
| Gross Profit/Loss - EUR | - | 22 | 6.302 | 10.437 | 22.291 | 24.388 | 27.969 | 46.101 | 70.538 | 78.075 |
| Net Profit/Loss - EUR | - | 15 | 6.069 | 10.014 | 21.448 | 23.618 | 27.036 | 44.947 | 69.747 | 75.432 |
| Employees | - | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Analex Reumato Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 0 | 0 | 0 | 0 | 1.277 | 535 | 0 | 652 | 259 |
| Current Assets | - | 248 | 6.221 | 10.215 | 21.930 | 24.570 | 31.095 | 46.933 | 72.566 | 104.937 |
| Inventories | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | 235 | 820 | 520 | 2.340 | 21.619 | 11.188 | 41.291 | 57.643 | 90.060 |
| Cash | - | 14 | 5.400 | 9.695 | 19.589 | 2.952 | 19.907 | 5.641 | 14.923 | 14.877 |
| Shareholders Funds | - | 59 | 6.127 | 10.066 | 21.498 | 23.667 | 27.084 | 44.996 | 69.795 | 75.480 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 189 | 93 | 149 | 432 | 2.366 | 4.546 | 1.937 | 3.423 | 30.014 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Analex Reumato Srl